The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 17, 2016
Filed:
Nov. 04, 2013
Applicant:
Glaxosmithkline Llc, Philadelphia, PA (US);
Inventors:
Nicholas David Adams, Collegeville, PA (US);
Christopher Joseph Aquino, Research Triangle Park, NC (US);
Amita M. Chaudhari, Collegeville, PA (US);
Jonathan Michael Ghergurovich, Collegeville, PA (US);
Terence John Kiesow, Collegeville, PA (US);
Cynthia Ann Parrish, Collegeville, PA (US);
Alexander Joseph Reif, Collegeville, PA (US);
Kenneth Wiggall, Collegeville, PA (US);
Assignee:
GlaxoSmithKline LLC, Wilmington, DE (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 249/12 (2006.01); A61K 31/4196 (2006.01); C07D 403/14 (2006.01); A61K 31/397 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 403/14 (2013.01); A61K 31/397 (2013.01); A61K 31/4196 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01);
Abstract
This invention relates to the use of triazolone derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.